期刊文献+
共找到378篇文章
< 1 2 19 >
每页显示 20 50 100
Drug-induced liver injury and COVID-19:Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice
1
作者 Gabriela Xavier Ortiz Ana Helena Dias Pereira dos Santos Ulbrich +4 位作者 Gabriele Lenhart Henrique Dias Pereirados Santos Karin Hepp Schwambach Matheus William Becker Carine Raquel Blatt 《Artificial Intelligence in Gastroenterology》 2023年第2期36-47,共12页
BACKGROUND Liver injury is a relevant condition in coronavirus disease 2019(COVID-19)inpatients.Pathophysiology varies from direct infection by virus,systemic inflammation or drug-induced adverse reaction(DILI).DILI d... BACKGROUND Liver injury is a relevant condition in coronavirus disease 2019(COVID-19)inpatients.Pathophysiology varies from direct infection by virus,systemic inflammation or drug-induced adverse reaction(DILI).DILI detection and monitoring is clinically relevant,as it may contribute to poor prognosis,prolonged hospitalization and increase indirect healthcare costs.Artificial Intelligence(AI)applied in data mining of electronic medical records combining abnormal liver tests,keyword searching tools,and risk factors analysis is a relevant opportunity for early DILI detection by automated algorithms.AIM To describe DILI cases in COVID-19 inpatients detected from data mining in electronic medical records(EMR)using AI and the updated Roussel Uclaf Causality Assessment Method(RUCAM).METHODS The study was conducted in March 2021 in a hospital in southern Brazil.The NoHarm©system uses AI to support decision making in clinical pharmacy.Hospital admissions were 100523 during this period,of which 478 met the inclusion criteria.From these,290 inpatients were excluded due to alternative causes of liver injury and/or due to not having COVID-19.We manually reviewed the EMR of 188 patients for DILI investigation.Absence of clinical information excluded most eligible patients.The DILI assessment causality was possible via the updated RUCAM in 17 patients.RESULTS Mean patient age was 53 years(SD±18.37;range 22-83),most were male(70%),and admitted to the non-intensive care unit sector(65%).Liver injury pattern was mainly mixed,mean time to normalization of liver markers was 10 d,and mean length of hospitalization was 20.5 d(SD±16;range 7-70).Almost all patients recovered from DILI and one patient died of multiple organ failure.There were 31 suspected drugs with the following RUCAM score:Possible(n=24),probable(n=5),and unlikely(n=2).DILI agents in our study were ivermectin,bicalutamide,linezolid,azithromycin,ceftriaxone,amoxicillin-clavulanate,tocilizumab,piperacillin-tazobactam,and albendazole.Lack of essential clinical information excluded most patients.Although rare,DILI is a relevant clinical condition in COVID-19 patients and may contribute to poor prognostics.CONCLUSION The incidence of DILI in COVID-19 inpatients is rare and the absence of relevant clinical information on EMR may underestimate DILI rates.Prospects involve creation and validation of alerts for risk factors in all DILI patients based on RUCAM assessment causality,alterations of liver biomarkers and AI and machine learning. 展开更多
关键词 chemical and drug induced liver injury RUCAM Artificial intelligence COVID-19 liver injury
下载PDF
Atypical onset of bicalutamide-induced liver injury 被引量:3
2
作者 Gee Young Yun Seok Hyun Kim +9 位作者 Seok Won Kim Jong Seok Joo Ju Seok Kim Eaum Seok Lee Byung Seok Lee Sun Hyoung Kang Hee Seok Moon Jae Kyu Sung Heon Young Lee Kyung Hee Kim 《World Journal of Gastroenterology》 SCIE CAS 2016年第15期4062-4065,共4页
Anti-androgen therapy is the leading treatment for advanced prostate cancer and is commonly used for neoadjuvant or adjuvant treatment. Bicalutamide is a non-steroidal anti-androgen, used during the initiation of andr... Anti-androgen therapy is the leading treatment for advanced prostate cancer and is commonly used for neoadjuvant or adjuvant treatment. Bicalutamide is a non-steroidal anti-androgen, used during the initiation of androgen deprivation therapy along with a luteinizing hormone-releasing hormone agonist to reduce the symptoms of tumor-related flares in patients with advanced prostate cancer. As side effects, bicalutamide can cause fatigue, gynecomastia, and decreased libido through competitive androgen receptor blockade. Additionally, although not as common, drug-induced liver injury has also been reported. Herein, we report a case of hepatotoxicity secondary to bicalutamide use. Typically, bicalutamideinduced hepatotoxicity develops after a few days; however, in this case, hepatic injury occurred 5 mo after treatment initiation. Based on this rare case of delayed liver injury, we recommend careful monitoring of liver function throughout bicalutamide treatment for prostate cancer. 展开更多
关键词 BICALUTAMIDE DRUG-induced liver INJURY PROSTATE neoplasm
下载PDF
Anabolic androgenic steroid-induced liver injury:An update
3
作者 Ana Petrovic Sonja Vukadin +5 位作者 Renata Sikora Kristina Bojanic Robert Smolic Davor Plavec George Y Wu Martina Smolic 《World Journal of Gastroenterology》 SCIE CAS 2022年第26期3071-3080,共10页
Anabolic androgenic steroids(AASs)are a group of molecules including endogenous testosterone and synthetic derivatives that have both androgenic and anabolic effects.These properties make them therapeutically benefici... Anabolic androgenic steroids(AASs)are a group of molecules including endogenous testosterone and synthetic derivatives that have both androgenic and anabolic effects.These properties make them therapeutically beneficial in medical conditions such as hypogonadism.However,they are commonly bought illegally and misused for their anabolic,skeletal muscle building,and performanceenhancing effects.Supraphysiologic and long-term use of AASs affects all organs,leading to cardiovascular,neurological,endocrine,gastrointestinal,renal,and hematologic disorders.Hepatotoxicity is one of the major concerns regarding AASs treatment and abuse.Testosterone and its derivatives have been most often shown to induce a specific form of cholestasis,peliosis hepatis,and hepatic benign and malignant tumors.It is currently believed that mechanisms of pathogenesis of these disorders include disturbance of antioxidative factors,upregulation of bile acid synthesis,and induction of hepatocyte hyperplasia.Most toxicity cases are treated with supportive measures and liver function normalizes with discontinuation of AAS.However,some long-term consequences are irreversible.AAS-induced liver injury should be taken in consideration in patients with liver disorders,especially with the increasing unintentional ingestion of supplements containing AAS.In this paper,we review the most current knowledge about AAS-associated adverse effects on the liver,and their clinical presentations,prevalence,and pathophysiological mechanisms. 展开更多
关键词 ANDROGENS STEROIDS CHOLESTASIS FIBROSIS liver chemical and drug induced liver injury
下载PDF
Overexpression of p27^(KIP1)induced cell cycle arrest in G_1 phase and subsequent apoptosis in HCC-9204 cell line 被引量:20
4
作者 Jiang Li Xin Ke Yang Xin Xin Yu Meng Liang Ge Wen Liang Wang Jie Zhang Yun De Hou Department of Pathology,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China State Key Laboratory for Molecular Virology and Genetic Engineering,Beijing 100052,China Department of Dermatology,Beijing Hospital,Beijing 100016,China Institute of Radiation Medicine,Beijing 100085,China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第4期513-521,共9页
AIM We have previously reported that inducible over-expresaion of Bak may prolong cell cycle in G1 phase and lead to apoptosis in HCC-9204 cells. This study is to investigate whether p27KIP1 plays an important role in... AIM We have previously reported that inducible over-expresaion of Bak may prolong cell cycle in G1 phase and lead to apoptosis in HCC-9204 cells. This study is to investigate whether p27KIP1 plays an important role in this process. MEHODS In order to elucidate the exact function of p27KIP1 in this process, a zinc inducible p27KIP1 stable transfectant and transient p27KIP1- GFP fusion transfectant were constructed. The effects of inducible p27KIP1 on cell growth, cell cycle arrest and apoptosis were examined in the mock, control pMD vector, and pMD-KIP1 transfected HCC-9204 cells. RESULTS This p27KIP1-GFP transfectant may transiently express the fusion gene. The cell growth was reduced by 35% at 48 h of p27KIP1 induction with zinc treatment as determined by trypan blue exclusion assay. These differences remained the same after 72 h of p27KIP1 expression, p27KIP1 caused cell cycle arrest after 24 h of induction, with 40% increase in G1 population. Prolonged p27KIP1 expression in this cell line induced apoptotic cell death reflected by TUNEL assay. Fourty-eight h and 72 h of p27KIP1 expression showed a characteristic DNA ladder on agarose gel electrophoresis. 展开更多
关键词 p27^(KIP1) APOPTOSIS cell cycle inducible expression system carcinoma hepatocellular liver neoplasms
下载PDF
Changes of integrin expression in rat hepatocarcinogenesis induced by 3′-Me-DAB 被引量:4
5
作者 Hayashi KeiKi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第2期231-233,共3页
AIM To investigate the expression of integrinsin rats liver during 3’-Me-DAB inducedhepatocarcinogenesis and to find out therelationship between integrins and liver cancermetastasis.METHODS The expressions of integri... AIM To investigate the expression of integrinsin rats liver during 3’-Me-DAB inducedhepatocarcinogenesis and to find out therelationship between integrins and liver cancermetastasis.METHODS The expressions of integrins α<sub>1</sub>,α<sub>2</sub>,α<sub>3</sub> and α<sub>5</sub> and epidermal keratin(EK)wereobserved by immunohistochemical PAP method.RESULTS In the normal liver tissues,hepatocytes express integrins α<sub>1</sub> and α<sub>5</sub> and inthe bile duct epithlium,EK.In liver cirrhosis,hepatocytes highly express integrins α<sub>1</sub>,α<sub>2</sub>,α<sub>3</sub>and α<sub>5</sub> and in hyperplastic bile duct epithelium,integrins α<sub>1</sub>,α<sub>5</sub> and EK.Expression of integrinsα<sub>1</sub>,α<sub>2</sub>,α<sub>3</sub> and α<sub>5</sub> were obviously decreased in thepreneoplastic nodules and primary carcinomabut expressions of integrins α<sub>1</sub> and α<sub>5</sub> inmetastasis in the lung and diaphragma werehigher than those in primary carcinoma.CONCLUSION Integrins α<sub>1</sub> and α<sub>5</sub> may play amajor role in chemically inducedhepatocarcinogenesis and metastasis in rats. 展开更多
关键词 INTEGRINS 3′-Me-DAB liver neoplasm/chemically induced neoplasm METASTASIS rats
下载PDF
Expression of Hypoxia-inducible Factor-1α in Liver Tumors after Transcatheter Arterial Embolization in an Animal Model 被引量:2
6
作者 梁斌 郑传胜 +4 位作者 冯敢生 王勇 赵辉 梁惠民 肖恩华 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第6期776-781,共6页
To examine the effect of transcatheter arterial embolization (TAE) of liver tumors on hypoxia-inducible factor-1α (HIF-1α) expression in the residual viable tumor, a total of 30 New Zealand White rabbits implant... To examine the effect of transcatheter arterial embolization (TAE) of liver tumors on hypoxia-inducible factor-1α (HIF-1α) expression in the residual viable tumor, a total of 30 New Zealand White rabbits implanted with VX2 liver tumor were divided into 2 groups. TAE-treated group animals (n=15) were subjected to TAE with 150–250 μm polyvinyl alcohol particles. Control group animals (n=15) underwent sham embolization with distilled water. Six hours, 3 days or 7 days after TAE, the animals were sacrificed, and samples of tumor and adjacent normal liver tissue were harvested. Expression of HIF-1α protein was examined immunohistochemically. Real-time PCR was performed to examine the HIF-1α mRNA levels. Our results showed that HIF-1α protein was expressed in the VX2 tumors but not in the adjacent normal liver tissue. The HIF-1α-positive tumor cells were located predominantly at the periphery of necrotic tumor regions. The mean levels of HIF-1α protein were significantly higher in TAE-treated tumors than those in control tumors (P=0.002). Among the three sacrificing time points, the difference in increase in HIF-1α protein was significant between the two groups at the sacrificing time point of 6 h and 3 days after TAE (P=0.020, P=0.031, respectively), whereas no significant increase was noted 7 days after TAE (P=0.502). In contrast, although HIF-1α mRNA was expressed in TAE-treated and control VX2 tumors, there existed no significant difference in the HIF-1α mRNA level between the two groups (P=0.372). It is concluded that TAE of liver tumors increases the expression of HIF-1α at protein level in the residual viable tumor, which could be attributed to hypoxia generated by the procedure. 展开更多
关键词 EMBOLIZATION hypoxia-inducible factor-1 liver neoplasms
下载PDF
Immune-mediated liver injury following COVID-19 vaccination 被引量:1
7
作者 Georgios Schinas Eleni Polyzou +3 位作者 Vasiliki Dimakopoulou Stamatia Tsoupra Charalambos Gogos Karolina Akinosoglou 《World Journal of Virology》 2023年第2期100-108,共9页
Liver injury secondary to vaccination is a rare adverse event that has recently come under attention thanks to the continuous pharmacovigilance following the widespread implementation of coronavirus disease 2019(COVID... Liver injury secondary to vaccination is a rare adverse event that has recently come under attention thanks to the continuous pharmacovigilance following the widespread implementation of coronavirus disease 2019(COVID-19)vaccination protocols.All three most widely distributed severe acute respiratory syndrome coronavirus 2 vaccine formulations,e.g.,BNT162b2,mRNA-1273,and ChAdOx1-S,can induce liver injury that may involve immune-mediated pathways and result in autoimmune hepatitis-like presentation that may require therapeutic intervention in the form of corticosteroid administration.Various mechanisms have been proposed in an attempt to highlight immune checkpoint inhibition and thus establish causality with vaccination.The autoimmune features of such a reaction also prompt an in-depth investigation of the newly employed vaccine technologies.Novel vaccine delivery platforms,e.g.,mRNA-containing lipid nanoparticles and adenoviral vectors,contribute to the inflammatory background that leads to an exaggerated immune response,while patterns of molecular mimicry between the spike(S)protein and prominent liver antigens may account for the autoimmune presentation.Immune mediators triggered by vaccination or vaccine ingredients per se,including autoreactive antibodies,cytokines,and cytotoxic T-cell populations,may inflict hepatocellular damage through wellestablished pathways.We aim to review available data associated with immunemediated liver injury associated with COVID-19 vaccination and elucidate potential mechanisms underlying its pathogenesis. 展开更多
关键词 Adverse effects COVID-19 vaccines mRNA vaccine Autoimmune Hepatitis chemical and Drug induced liver Injury AUTOIMMUNITY
下载PDF
血清总胆汁酸检测在儿童早期药物性肝损害监测中的应用
8
作者 郭磊 张帅 《实用医技杂志》 2024年第7期505-507,共3页
目的探讨儿童早期药物性肝损害监测中血清总胆汁酸(TBA)检测的应用价值。方法回顾性选取2020年2月至2022年2月本院儿童早期药物性肝损害患儿50例作为病例组、健康体检人员50名作为健康组。统计分析2组各检测指标值、阳性情况,并统计分... 目的探讨儿童早期药物性肝损害监测中血清总胆汁酸(TBA)检测的应用价值。方法回顾性选取2020年2月至2022年2月本院儿童早期药物性肝损害患儿50例作为病例组、健康体检人员50名作为健康组。统计分析2组各检测指标值、阳性情况,并统计分析病例组不同损害程度患儿的各检测指标值、阳性情况。结果病例组患儿血清TBA、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、γ-谷氨酰转氨酶(GGT)、总胆红素(TBIL)水平均高于健康组(P<0.05)。病例组患儿血清TBA阳性率24.0%(12/50)高于健康组2.0%(1/50)(χ2=10.699,P=0.001),但2组儿童的血清AST、ALT、GGT、TBIL阳性率差异均无统计学意义(P>0.05)。病例组轻度、中度、重度损害患儿的血清TBA、AST、ALT、GGT、TBIL水平均逐渐升高(P<0.05)。病例组轻度、中度、重度损害患儿血清TBA阳性率逐渐升高(P<0.05),但AST、ALT、GGT、TBIL阳性率差异均无统计学意义(P>0.05)。结论儿童早期药物性肝损害监测中血清TBA检测的应用价值高。 展开更多
关键词 儿童 化学性与药物性肝损伤 胆汁酸类
下载PDF
药物性肝损伤患者预后影响因素分析及列线图模型的建立 被引量:1
9
作者 王诗美 靳帅 +5 位作者 李俊儒 王娜 陈岩 崔莹 马明明 胡晓丽 《临床肝胆病杂志》 CAS 北大核心 2024年第3期562-567,共6页
目的探讨药物性肝损伤(DILI)患者临床转归的影响因素,构建列线图模型并进行内部验证。方法回顾性分析哈尔滨工业大学附属黑龙江省医院2017年1月—2022年12月收治的188例DILI患者的一般资料和实验室数据,根据患者临床转归分为结局良好组(... 目的探讨药物性肝损伤(DILI)患者临床转归的影响因素,构建列线图模型并进行内部验证。方法回顾性分析哈尔滨工业大学附属黑龙江省医院2017年1月—2022年12月收治的188例DILI患者的一般资料和实验室数据,根据患者临床转归分为结局良好组(n=146)和不良结局组(n=42)。正态分布计量资料两组间比较采用成组t检验;非正态分布计量资料两组间比较采用Mann-Whitney U检验。计数资料两组间比较采用χ^(2)检验。通过单因素和多因素Logistic回归分析筛选DILI患者临床转归相关的独立影响因素。R Studio 4.1.2软件构建列线图模型,通过校准曲线、受试者工作特征曲线(ROC曲线)和决策曲线分析(DCA)对模型进行内部验证。结果单因素Logistic回归分析结果显示,肝活检诊断DILI、PLT、ChE、Alb、PTA、IgM和IgG与DILI患者不良结局相关(P值均<0.05)。多因素Logistic回归分析结果显示,肝活检诊断DILI(OR=0.072,95%CI:0.022~0.213,P<0.001)、临床分型(OR=0.463,95%CI:0.213~0.926,P=0.039)、ALT(OR=0.999,95%CI:0.998~1.000,P=0.025)、PTA(OR=0.973,95%CI:0.952~0.993,P=0.011)和Ig M(OR=1.456,95%CI:1.082~2.021,P=0.015)是DILI患者临床转归的独立影响因素。构建列线图,经验证校准曲线接近参考曲线,ROC曲线下面积为0.829,决策曲线分析显示该模型具有良好的临床净收益。结论构建的列线图模型对评估DILI患者的临床转归具有较好的临床校准度、鉴别能力和应用价值。 展开更多
关键词 化学性与药物性肝损伤 预后 列线图
下载PDF
不同评估量表在药物性肝损伤中的诊断价值分析 被引量:1
10
作者 马嘉蹊 姚甜甜 +7 位作者 程浩 刘丹 张宇涵 杜思源 董琳菲 胡林慧 王艳 王贵强 《临床肝胆病杂志》 CAS 北大核心 2024年第6期1203-1208,共6页
目的采用RUCAM评估量表、Maria&Victorino评估量表、RECAM评估量表3种因果关系评估量表分别对药物性肝损伤(DILI)确诊病例进行评分,比较3种量表之间的诊断准确性差异,探讨其对于DILI诊断的临床意义。方法纳入2011年1月—2022年12月... 目的采用RUCAM评估量表、Maria&Victorino评估量表、RECAM评估量表3种因果关系评估量表分别对药物性肝损伤(DILI)确诊病例进行评分,比较3种量表之间的诊断准确性差异,探讨其对于DILI诊断的临床意义。方法纳入2011年1月—2022年12月于北京大学第一医院住院、肝组织学活检病理结果支持DILI及有明确用药史的98例DILI确诊患者。采集研究对象的临床资料,并用上述因果关系评估量表评分,应用χ^(2)检验分析因果关系评估量表的诊断准确性,应用加权kappa系数(κw系数)分析因果关系评估量表的一致性。结果在纳入的所有DILI患者中,RECAM评估量表的准确性最高,与RUCAM评估量表比较差异有统计学意义(χ^(2)=5.667,P=0.017)。RUCAM评估量表和RECAM评估量表的诊断一致性中等(κw=0.469),而RECAM评估量表和Maria&Victorino评估量表的诊断一致性较差(κw=0.156)。在急性DILI患者中,RECAM量表、RUCAM量表、Maria&Victorino量表的不符合诊断率分别为3.7%、11.1%、42.6%;在肝细胞型DILI患者中,RECAM量表、RUCAM量表、Maria&Victorino量表的不符合诊断率分别为8.9%、21.4%、62.5%;在胆汁淤积型和混合型DILI患者中,RECAM量表、RUCAM量表、Maria&Victorino量表的不符合诊断率分别为10.0%、22.5%、47.5%。结论在急性DILI中使用RECAM评估量表和RUCAM评估量表能提高诊断率;在肝细胞型DILI和临床表现包含胆汁淤积的DILI(胆汁淤积型DILI和混合型DILI)中使用RECAM评估量表和RUCAM评估量表能提高诊断率;根据不同的病程及临床分型选择诊断准确性较高的因果关系评估量表有助于进一步提高临床诊断率。 展开更多
关键词 化学性与药物性肝损伤 诊断 评估量表
下载PDF
药物诱导的自身免疫样肝炎的研究进展
11
作者 李勤荣 尧颖 徐智媛 《临床肝胆病杂志》 CAS 北大核心 2024年第6期1255-1258,共4页
药物诱导的自身免疫样肝炎(DI-ALH)是药物性肝损伤的一种特殊临床表型,与自身免疫性肝炎有相似的临床特征和实验室检查,多数时候通过肝组织活检也无法直接区分,因此正确鉴别DI-ALH与自身免疫性肝炎是临床实践中的重难点。本文总结了DI-... 药物诱导的自身免疫样肝炎(DI-ALH)是药物性肝损伤的一种特殊临床表型,与自身免疫性肝炎有相似的临床特征和实验室检查,多数时候通过肝组织活检也无法直接区分,因此正确鉴别DI-ALH与自身免疫性肝炎是临床实践中的重难点。本文总结了DI-ALH的发病机制、临床特点、诊治、预后的研究进展,为临床医生提供此类疾病的诊治思路。 展开更多
关键词 化学性与药物性肝损伤 肝炎 自身免疫性 诊断 治疗学
下载PDF
中草药相关肝损伤的管理与治疗
12
作者 孙鑫 罗琼 +1 位作者 杨涛 刘成海 《临床肝胆病杂志》 CAS 北大核心 2024年第8期1538-1542,共5页
由于我国中草药产品应用形式多样,使用人群广泛,用药情况复杂,近年来中草药相关肝损伤等不良反应事件频发,为进一步科学认识中草药相关肝损伤,规范其风险管理与防治措施,本文结合近年的临床研究进展与相关经验,对中草药相关肝损伤的风... 由于我国中草药产品应用形式多样,使用人群广泛,用药情况复杂,近年来中草药相关肝损伤等不良反应事件频发,为进一步科学认识中草药相关肝损伤,规范其风险管理与防治措施,本文结合近年的临床研究进展与相关经验,对中草药相关肝损伤的风险管理、临床评价、预防及治疗展开论述。在中药研发生产、上市后的临床应用等多环节,建立涉及中药产品质量控制、患者安全教育、临床医师合理用药、定期监测、分级分型治疗等全方位的中草药相关肝损伤的管控体系,对于预防和处理肝损伤等不良反应事件非常重要,为中草药临床安全合理用药提供参考和借鉴。 展开更多
关键词 中草药 化学性与药物性肝损伤 治疗学
下载PDF
肝再生在对乙酰氨基酚诱导的肝损伤修复中的作用
13
作者 莫胤康 范子豪 任锋 《临床肝胆病杂志》 CAS 北大核心 2024年第9期1902-1907,共6页
肝再生在对乙酰氨基酚(APAP)诱导的肝损伤后恢复中有着至关重要的作用。APAP过量服用后,通常是肝损伤程度越大,再生的程度就越大,从而导致肝损伤的消退和大多数情况下的自发恢复。然而,严重APAP过量会导致肝再生受损和无法控制的肝损伤... 肝再生在对乙酰氨基酚(APAP)诱导的肝损伤后恢复中有着至关重要的作用。APAP过量服用后,通常是肝损伤程度越大,再生的程度就越大,从而导致肝损伤的消退和大多数情况下的自发恢复。然而,严重APAP过量会导致肝再生受损和无法控制的肝损伤,导致无法恢复,甚至死亡。在APAP肝损伤后,肝脏中细胞之间的相互作用对再生反应非常重要。肝再生由多种增殖信号通路共同调控,这些通路涉及激酶、核受体、转录因子、转录共激活因子。严重的APAP过量后会抑制增殖信号通路的激活,导致细胞周期停滞和肝再生受损。虽然肝再生在APAP肝损伤后的修复过程中发挥关键作用,但目前其发挥作用的潜在机制尚不明确。本文就已有的相关研究对肝再生在APAP诱导的肝损伤中的作用进行综述,为进一步的基础研究提供参考。 展开更多
关键词 化学性与药物性肝损伤 对乙酰氨基酚 信号传导 修复
下载PDF
小窝蛋白1在肝脏疾病中的调控作用
14
作者 朱骏毅 李瑞蕊 +1 位作者 舒仪雪 孙泉 《临床肝胆病杂志》 CAS 北大核心 2024年第6期1269-1274,共6页
小窝蛋白(CAV)1是质膜上小窝的结构蛋白,是肝脏功能的重要调节因子。CAV1可通过多种分子通路调节肝脏脂质沉积、脂质和葡萄糖代谢、线粒体功能和肝细胞增殖等。因此,CAV1在肝脂肪变性和肝细胞增殖等代谢调节过程中维持肝脏生理方面起着... 小窝蛋白(CAV)1是质膜上小窝的结构蛋白,是肝脏功能的重要调节因子。CAV1可通过多种分子通路调节肝脏脂质沉积、脂质和葡萄糖代谢、线粒体功能和肝细胞增殖等。因此,CAV1在肝脂肪变性和肝细胞增殖等代谢调节过程中维持肝脏生理方面起着至关重要的作用。此外,CAV1还参与调节不同类型肝损伤、肝炎、肝硬化等疾病的发生发展过程。本文就CAV1在肝脏及相关疾病中的作用及调控肝巨噬细胞的机制进行综述,为靶向CAV1治疗肝脏相关疾病提供理论依据。 展开更多
关键词 小窝蛋白1 化学性与药物性肝损伤 肝纤维化 巨噬细胞
下载PDF
中成药致药物性肝损伤159例回顾性分析
15
作者 朱晓静 周梁 《安徽医药》 CAS 2024年第8期1689-1693,共5页
目的探讨中成药致药物性肝损伤(DILI)的发生原因、发生特征,以期规范中成药的使用,减少中成药相关不良反应。方法回顾性分析2015年1月至2022年12月苏州市中西医结合医院中成药致DILI病人159例,记录病人的基本情况(性别、年龄)、原发疾... 目的探讨中成药致药物性肝损伤(DILI)的发生原因、发生特征,以期规范中成药的使用,减少中成药相关不良反应。方法回顾性分析2015年1月至2022年12月苏州市中西医结合医院中成药致DILI病人159例,记录病人的基本情况(性别、年龄)、原发疾病、用药史、临床特征、实验室检查结果等。结果中成药致DILI的发生与病人年龄分布和有无基础疾病有关,而与性别无关;涉及的中成药总共有16种,主要用于治疗妇科及乳腺疾病、皮肤病、骨科疾病、心脑血管疾病以及肾脏疾病。使用骨康胶囊引发的药物性肝损病人有31例,占比19.50%;其次是仙灵骨葆胶囊,占比11.95%;占比排名第三的是接骨七厘片/丸(18例,11.32%);骨科疾病的病人服用相关中成药的时间较长。159例确诊病人涵盖了药物性肝损伤的三种分型,包括肝细胞损伤型(76例,47.80%)、混合型(51例,32.08%)、胆汁淤积型(32例,20.13%),肝细胞损伤型病人占比最高。其中,半数以上为轻度肝损伤(81例,50.94%)。结论在中医药理论指导下,严格遵循中医辨证施治的治疗原则,科学、规范应用中药,是提高用药安全性、减少中成药所致药物性肝损伤的重要措施。 展开更多
关键词 化学性与药物性肝损伤 中成药 药物性肝损伤 用药安全
下载PDF
中草药相关肝损伤的诊断:实践中的挑战
16
作者 董一诺 支阳 +1 位作者 唐洁婷 茅益民 《临床肝胆病杂志》 CAS 北大核心 2024年第8期1533-1537,共5页
随着草药和膳食补充剂(HDS)在全球范围内的应用日益广泛,中草药相关肝损伤(HILI)已成为药物性肝损伤的重要病因。由于HILI表现多样、病史采集困难、缺乏特异性生物标志物等原因,如何及时发现疑似患者并建立正确诊断成为实践过程中的主... 随着草药和膳食补充剂(HDS)在全球范围内的应用日益广泛,中草药相关肝损伤(HILI)已成为药物性肝损伤的重要病因。由于HILI表现多样、病史采集困难、缺乏特异性生物标志物等原因,如何及时发现疑似患者并建立正确诊断成为实践过程中的主要难题。目前诊断HILI的过程中多用到因果关系评估,但缺乏大样本前瞻性队列验证。此外,对于HILI诊断的特异性生物标志物仍有待进一步研究。HILI的诊断和鉴别诊断是极具挑战性的问题,目前尚无公认的统一、标准的方法适用于全因HILI的诊断。 展开更多
关键词 中草药 化学性与药物性肝损伤 诊断 因果关系评估 生物标志
下载PDF
中草药相关肝损伤的物质基础及其毒性机制
17
作者 刘雪莹 师荟荟 +1 位作者 王浩文 杨涛 《临床肝胆病杂志》 CAS 北大核心 2024年第8期1512-1518,共7页
中草药相关肝损伤的毒性物质基础及其毒性机制复杂,影响中药的安全应用。本文对中草药引起肝损伤的主要毒性成分及其作用机制进行了归纳分析,中草药肝损伤毒性成分可以分为药源性与非药源性两大类,药源性毒性成分主要有生物碱类、萜类... 中草药相关肝损伤的毒性物质基础及其毒性机制复杂,影响中药的安全应用。本文对中草药引起肝损伤的主要毒性成分及其作用机制进行了归纳分析,中草药肝损伤毒性成分可以分为药源性与非药源性两大类,药源性毒性成分主要有生物碱类、萜类、蒽醌类以及苯丙素类化合物,作用机制涉及氧化应激、细胞凋亡与坏死、CYP450酶、基因毒性等。非药源性物质主要有农药残留、二氧化硫残留、重金属、真菌、植物生长调节剂,机制涉及氧化应激、凋亡、代谢紊乱、CYP450酶等。在此基础上进一步提出了目前待解决的问题与研究难点,以期促进中草药肝毒性的基础研究。 展开更多
关键词 中草药 化学性与药物性肝损伤 物质基础
下载PDF
新型冠状病毒感染抗病毒药物引起肝损伤的发生机制 被引量:1
18
作者 曾雪 李福青 +1 位作者 李清清 王红 《临床肝胆病杂志》 CAS 北大核心 2024年第2期402-407,共6页
药物性肝损伤是药物使用过程中因药物本身和/或其代谢产物,或由于特殊体质对药物的超敏感性或耐受性降低所导致。在近三年抗击新型冠状病毒感染(COVID-19)的诊治过程中,抗病毒药物起到了非常重要的作用,但国内外关于抗COVID-19药物引起... 药物性肝损伤是药物使用过程中因药物本身和/或其代谢产物,或由于特殊体质对药物的超敏感性或耐受性降低所导致。在近三年抗击新型冠状病毒感染(COVID-19)的诊治过程中,抗病毒药物起到了非常重要的作用,但国内外关于抗COVID-19药物引起肝损伤的报道较多,且其导致肝损伤的发生机制尚未明确。本文对COVID-19抗病毒药物的种类及其引起肝损伤机制的相关研究进展作一综述,旨在促进抗病毒药物的合理使用。 展开更多
关键词 化学性与药物性肝损伤 新型冠状病毒 病理过程
下载PDF
中草药相关肝损伤的研究进展与挑战
19
作者 刘成海 《临床肝胆病杂志》 CAS 北大核心 2024年第8期1505-1511,共7页
中草药相关肝损伤发生众多,对中药临床安全用药与产业健康发展等有重要影响,近年来中草药肝损伤研究受到广泛重视并取得显著进展,我国与国际学术组织均制订并更新了相关临床诊疗指南。本文比较分析了近期有关中草药相关肝损伤诊疗指南... 中草药相关肝损伤发生众多,对中药临床安全用药与产业健康发展等有重要影响,近年来中草药肝损伤研究受到广泛重视并取得显著进展,我国与国际学术组织均制订并更新了相关临床诊疗指南。本文比较分析了近期有关中草药相关肝损伤诊疗指南的特点,继而从毒性机制、临床诊断与病情评估、风险因素与临床防治等方面简述主要进展,提出部分尚未满足的需求、需要重视的研究难点与可能的防治措施。 展开更多
关键词 中草药 化学性与药物性肝损伤 毒理机制 诊断 危险因素 治疗学
下载PDF
药物联合应用对中草药相关肝损伤的影响
20
作者 郑晖 孙蓉 《临床肝胆病杂志》 CAS 北大核心 2024年第8期1519-1524,共6页
随着中医药在全球范围内的广泛使用和临床中药物联用情况的增多,中草药相关肝损伤(HILI)和药物安全性事件频发,这给中药新药研发和中医产业发展带来了重大挑战。目前,在系统归纳总结药物联用对HILI的影响,梳理其临床特征、发生过程和互... 随着中医药在全球范围内的广泛使用和临床中药物联用情况的增多,中草药相关肝损伤(HILI)和药物安全性事件频发,这给中药新药研发和中医产业发展带来了重大挑战。目前,在系统归纳总结药物联用对HILI的影响,梳理其临床特征、发生过程和互作机制,尤其是研究中西药联用后的药效动力学和药代毒理学过程等方面,仍然存在较大不足。亟需进一步构建系统整合的研究体系,特别是在靶标分子、细胞间交流、组织间串扰和体内毒性评价等方面,开展更加精准、特异和早期的研究。通过临床与基础并行的病证基础研究,提出符合中医药理论和应用规律的HILI防控策略,将为提升病证场景下的中西药物联用水平提供基础支撑和可信证据。 展开更多
关键词 中草药 化学性与药物性肝损伤 药物疗法 联合 药物相互作用
下载PDF
上一页 1 2 19 下一页 到第
使用帮助 返回顶部